WARSAW, Ind., Aug. 31, 2021 /PRNewswire/ -- Zimmer Biomet
Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology
leader, today announced four data presentations on the
clinical value of mymobility® with Apple
Watch®, a first-of-a-kind remote care management
platform designed to help healthcare professionals remotely support
and guide patients as they prepare for and recover from orthopedic
procedures. mymobility with Apple Watch is a part of ZBEdge™,
Zimmer Biomet's suite of connected digital and robotic technologies
designed to deliver actionable insights with the goal of improving
patient outcomes. The data are being presented at the American
Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting being
held on August 31 to September 3 in
San Diego.
"The introduction of mymobility with Apple Watch underscores
Zimmer Biomet's commitment to evaluating the real-world clinical
benefits of a remote care management platform after orthopedic
surgery," said Robert Kraal, Vice President and General Manager,
Connected Health at Zimmer Biomet. "These four analyses, utilizing
interim data from the ongoing mymobility Clinical Study, suggest
that mymobility with Apple Watch may be a viable option to help
healthcare professionals monitor how a patient is progressing after
surgery and remotely manage rehabilitation regimens to optimize
recovery."
Details on the four data presentations can be found below.
PODIUM SESSION: Paper
458 - A Smartwatch Paired Mobile Application Provides
Postoperative Self-Directed Rehabilitation Without Compromising
Patient Outcomes: A Randomized Controlled Trial
Session: Adult Reconstruction Knee IV
September 2, 2021
8:50AM – 8:55AM PT
Ballroom 6A
- Evaluated 337 patients who underwent primary total knee
arthroplasty (TKA) to determine the impact on postoperative
outcomes with the use of a self-directed rehabilitation (SDR)
program after TKA. The SDR was administered via the mymobility
application which provided pre- and post-operative education and
video-directed exercise programs and was paired with an Apple Watch
to help track the patient's physical activity*.
- Patients were divided into three groups: a control group who
had formal physical therapy (184 patients), a high
exercise-compliance SDR treatment group (90 patients) and a low
exercise-compliance SDR group (63 patients).
- Patient reported outcome measures (PROMs) of knee injury and
osteoarthritis outcome scores, joint replacement (KOOS, JR) along
with knee range of motion and manipulation rates were
evaluated.
- Results showed no clinically significant differences between
groups for all evaluated outcomes at 3, 6 or 12 months.
- Study Outcome: Researchers concluded that a
postoperative SDR program administered through a mobile application
paired with a smartwatch can provide similar patient-reported
outcome measures while not affecting manipulation rates or
compromising range of motion, regardless of the level of compliance
with the application exercise program.
"Our study was able to demonstrate that total knee replacement
surgery patients using a remote care model with mymobility and an
Apple Watch were able to achieve clinically similar outcomes
compared to patients who received the traditional standard of care,
regardless of their level of exercise compliance," said
Krishna Tripuraneni, MD, FAAOS,
orthopedic surgeon at New Mexico Orthopaedics and the study's lead
author. "The data suggest that a smartphone-based care platform
featuring mymobility could be a viable alternative to the standard
of care for post-operative knee replacement care."
POSTER SESSION: P0765 - Use of a
Smartphone-Based Care Platform after Primary Joint Arthroplasty: A
Prospective Randomized Trial
September 2, 2021,
7:00AM – 5:00PM PT (Academy Hall – Sails Pavilion)
- Evaluated 828 patients who underwent primary hip or knee
arthroplasty to determine the difference in 90-day healthcare
utilization between a smartphone-based versus traditional care
platform.
- Patients were randomized into two groups: a control group (447
patients) who received the institution's traditional standard of
care, and a treatment group (381 patients) who received the
mymobility application with an Apple Watch. Outcomes assessed were
physical therapy (PT) visits, readmissions and emergency department
(ED)/urgent care (UC) visits.
- Study Outcome: Findings of this randomized trial
demonstrate non-inferiority of the primary endpoint comparing the
mymobility platform group to the control group on 90-day
readmissions.
"This study demonstrated that compared to patients treated with
the standard of care after surgery, mymobility patients utilized
less of the studied healthcare resources which, we hypothesize,
could aid in decreasing postoperative costs," said David Crawford, MD, orthopedic surgeon at JIS
Orthopedics and the study's lead author.
POSTER SESSION: P0542 - The Recovery Curve
for Physical Activity following Primary Total Hip Arthroplasty
Using Average Daily Step Counts Measured with a Smartphone Based
Case Platform and Smart Watch
September 2, 2021,
7:00AM – 5:00PM PT (Academy Hall – Sails Pavilion)
- Designed to characterize the recovery curve based on passively
collected physical activity after total hip arthroplasty (THA)
using average step counts and flight counts (flights of stairs)
measured by mymobility with Apple Watch.
- Study Outcome: Analyses of the interim data of 778
patients found that using these passively collected outcome
measures (PCOM) to assess the rate of recovery (the pace at which
patients return to preoperative activity levels) was similar to
previously reported recovery curves for patient reported outcomes
measures (PROM) 1.
"Before the availability of wearables and remote care management
applications that can passively collect movement data and other
indicators of post-surgical recovery, surgeons relied on patient
reported outcome measures to assess a patient's progress," said Dr.
Crawford, the study's lead author. "Our analysis suggests that
passively collected physical activity data using mymobility with
Apple Watch may be as useful as PROMs to set goals and monitor
recovery after total hip replacement surgery."
POSTER SESSION: P0528 -
The Relationship of Common Patient Reported Outcomes and
Passively Collected Outcome Measures in the Adult Reconstruction
Arena
September 2, 2021,
7:00AM – 5:00PM PT (Academy Hall – Sails Pavilion)
- Analyzed data from 778 patients who underwent primary total
hip, or total and unicondylar knee arthroplasty and had at least
one PROM and one PCOM.
- Study Outcome: When the relationship between overall
PROM scores and PCOMs was evaluated, there did not appear to be a
correlation; however, there were associations between PCOMs and
PROMs about pain, walking, standing and activity levels.
"The associations we observed between passively collected data
on step and stair counts and patient reported data on metrics such
as pain and walking support the value of incorporating smart remote
monitoring technology into the traditional rehabilitation pathways
for hip or knee surgery," added Dr. Crawford, the study's leading
author.
Full abstracts of the planned presentations are available at
https://www.aaos.org/annual/education/browse-education/.
mymobility with Apple Watch and iPhone acts as a
virtual care team member by providing patients with support
and guidance at the direction of their healthcare professional as
they prepare for and recover from orthopedic procedures from the
comfort of their home. For patients who have a compatible
smartphone, and who are clinically suited for remote care,
mymobility leverages the powerful sensors on Apple Watch and iPhone
to measure a patient's activity (e.g., number of steps, walking
asymmetry, walking speed, flights of stairs) and post-operative
progress. mymobility with Apple Watch also enables virtual
connections between patients and healthcare professionals
throughout the surgical episode of care, with the goal of lowering
the overall cost of care. Pre- and post-operative data collected by
mymobility with Apple Watch is combined with intraoperative data
from patients who undergo joint replacement with ROSA®
Robotics and is then seamlessly consolidated and analyzed by
OrthoIntel Orthopedic Intelligence Platform, to uncover new
clinical insights throughout the episode of care and to help
surgeons and care teams make informed patient care decisions. To
learn more about mymobility with Apple Watch, please visit
zimmerbiomet.com/mymobility.
About the Company
Zimmer Biomet is a global medical technology leader with a
comprehensive portfolio designed to maximize mobility and improve
health. We seamlessly transform the patient experience through our
innovative products and suite of integrated digital and robotic
technologies that leverage data, data analytics and artificial
intelligence.
With 90+ years of trusted leadership and proven expertise,
Zimmer Biomet is positioned to deliver the highest quality
solutions to patients and providers. Our legacy continues to come
to life today through our progressive culture of evolution and
innovation.
For more information about our product portfolio, our operations
in 25+ countries and sales in 100+ countries or about joining our
team, visit www.zimmerbiomet.com or follow Zimmer Biomet on
Twitter at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking
Statements
This news release contains forward-looking statements within
the meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
include, but are not limited to, statements concerning Zimmer
Biomet's expectations, plans, prospects, and product and service
offerings, including new product launches and potential clinical
successes. Such statements are based upon the current beliefs and
expectations of management and are subject to significant risks,
uncertainties and changes in circumstances that could cause actual
outcomes and results to differ materially. For a list and
description of some of such risks and uncertainties, see Zimmer
Biomet's periodic reports filed with the U.S. Securities
and Exchange Commission (SEC). These factors should not be
construed as exhaustive and should be read in conjunction with the
other cautionary statements that are included in Zimmer Biomet's
filings with the SEC. Forward-looking statements speak only as
of the date they are made, and Zimmer Biomet disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise. Readers of this news release are cautioned not
to rely on these forward-looking statements, since there can be no
assurance that these forward-looking statements will prove to be
accurate. This cautionary statement is applicable to all
forward-looking statements contained in this news release.
Apple Watch and iPhone are trademarks of Apple, Inc., registered
in the US and other countries.
ZBH-Corp
* The treatment group was not initially
prescribed physical therapy, but could be if their surgeons deemed
it necessary.
1 1. Kagan R, Anderson MB, Christensen JC,
Peters CL, Gililland JM, Pelt CE. The Recovery Curve for the
Patient-Reported Outcomes Measurement Information System
Patient-Reported Physical Function and Pain Interference
Computerized Adaptive Tests After Primary Total Knee Arthroplasty.
J Arthroplasty 33(8): 2471, 2018
Contacts:
|
|
|
|
Media
|
|
Meredith
Weissman
|
|
(703)
346-3127
|
|
meredith.weissman@zimmerbiomet.com
|
|
|
|
Investors
|
|
Ezgi Yagci
|
Keri
Mattox
|
(617)
549-2443
|
(203)
399-0856
|
ezgi.yagci@zimmerbiomet.com
|
keri.mattox@zimmerbiomet.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-new-data-supporting-clinical-benefits-of-mymobility-with-apple-watch-at-aaos-2021-301365583.html
SOURCE Zimmer Biomet Holdings, Inc.